What is the Optimal Treatment Duration for Outpatient Pediatric Community-Acquired Pneumonia?

Ann Emerg Med. 2024 Mar;83(3):214-216. doi: 10.1016/j.annemergmed.2023.09.006. Epub 2023 Oct 19.

Authors

Hannah Wilkins¹, Nicholas Hobart-Porter¹, Carly Eastin²

Affiliations

¹ Division of Pediatric Emergency Medicine, Pharmacology, and Toxicology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR.
² Department of Emergency Medicine, Division of Pediatric Emergency Medicine, Pharmacology, and Toxicology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR.

PMID: 37855789
DOI: 10.1016/j.annemergmed.2023.09.006

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / therapeutic use
Child
Community-Acquired Infections* / drug therapy
Duration of Therapy
Humans
Outpatients
Pneumonia* / drug therapy

Substances

Anti-Bacterial Agents